2 Days
المصدر:
The Washington Post
Controversial sleep and pain products gain support
FDA scientists advised against approving the peptides due to insufficient clinical trial data on their safety and effectiveness.
articleDetails.fontSize.sizeحجم النص
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading